Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies

Sickle cell disease is induced by a mutation that converts normal adult hemoglobin to sickle hemoglobin (HbS) and engenders intracellular polymerization of deoxy-HbS and erythrocyte sickling. Development of anti-sickling therapies requires quantitative understanding of HbS polymerization kinetics un...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Lu, Li, Zhen, Li, He, Li, Xuejin, Vekilov, Peter G., Karniadakis, George Em
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703859/
https://www.ncbi.nlm.nih.gov/pubmed/31457104
http://dx.doi.org/10.1126/sciadv.aax3905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703859/
https://www.ncbi.nlm.nih.gov/pubmed/31457104
http://dx.doi.org/10.1126/sciadv.aax3905

Ejemplares similares